111, Inc. (YI) stock
Close on Nov 13, 2026Market cap $49.90MP/E –Yield –
111, Inc. saw revenue fall 12.8% to CN¥12.56B over fiscal 2025. Operating income fell 212.4% to -CN¥2.38M, moving the operating margin from 0.0% to -0.0%. Free cash flow was CN¥114.69M, down 53.7% from a year earlier. At the latest close the market valued the company at CN¥333.13M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- CN¥333.13M
- P/E ratio
- –
- Price to sales
- 0.03
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 34.43%
Fundamentals
- Revenue
- CN¥12.56B
- EPS, diluted
- -0.38 CNY
- Free cash flow
- CN¥114.69M
Trading
- Previous close
- $2.85
- Open
- $2.87
- Day's range
- $2.84 – $2.93
- Volume
- 4,258
- Average volume (20 days)
- 17,425
- Beta (5 years)
- 1.15
- RSI (14 days)
- 36.4
- Volatility (1 year)
- 90.1%
- Relative volume
- 0.32×
- WACC
- 11.2%
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | YI | S&P 500 | Difference | YI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.4% | -3.0% | −5.3 pts | ||
| 3 months | -25.3% | -2.8% | −22.5 pts | ||
| Year to date | +10.9% | +11.5% | −0.6 pts | ||
| 1 year | -29.9% | +13.5% | −43.3 pts | ||
| 3 years | -87.4% | +77.7% | −165.1 pts | -49.9% | +21.1% |
| 5 years | -94.8% | +72.6% | −167.4 pts | -44.6% | +11.5% |
Eleven years at a glance
Fiscal years 2015 to 2025, CNY
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases 111 filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About 111
Retail-Drug Stores and Proprietary Stores
111, Inc. operates an integrated digital healthcare platform in China that connects pharmaceutical companies, pharmacies, and consumers. The company distributes pharmaceutical and healthcare products through wholesale and retail channels, utilizing both direct sales and an online marketplace model. Its wholesale platform, 1 Pharmacy, serves pharmacies, clinics, and hospitals with centralized procurement, supply chain integration, smart procurement services, cloud-based inventory management, and financing solutions. In addition, the platform offers commercialization, marketing, and channel data analytics to upstream pharmaceutical manufacturers.
Company profile, executives and history111 stock: common questions
What is 111's stock price?
YI closed at $2.84 on Nov 13, 2026, down 0.35% on the day.
What is 111's market cap?
111 was worth $49.90M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is YI's P/E ratio?
111 lost money over fiscal 2025 (diluted EPS -0.38 CNY), so it has no meaningful P/E ratio.
How much revenue does 111 make?
111 reported revenue of CN¥12.56B for fiscal 2025, down 12.8% from a year earlier.
Does 111 pay a dividend?
No. 111 has not paid a cash dividend over the last twelve months.
How has YI stock performed over the past year?
Including dividends, YI returned -29.9% over the past year, against +13.5% for the S&P 500.
Who are 111's competitors?
Companies most similar to 111 by business, industry and size include BZUN, CHWY, DDL, ULTA, RDGT.
See a number that looks wrong?